Delivery Order SPE2DB22D1106-SPE2DB25FEYB8
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,422.19 to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded contract utilizes firm fixed price terms with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location in Conshohocken, PA 19428....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for 100 tablets of Onfil 10 mg, with a ceiling value of $1,979.06 and an ultimate completion date of July 24, 2025. This is a firm fixed-price contract with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $4,906.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for 100 tablets of Onfil 10 mg. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,150.72 to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Onfil 20 mg tablets (100-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation, scheduled for completion by September 29, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Onfil 10 mg tablets (100-count units) valued at $11,683.85 under a firm fixed-price contract type. The award, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $4,638.32 to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg, with performance in Conshohocken, Pennsylvania. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 26, 2025. The delivery order was awarded on August 25, 2025, and represents a single pharmaceutical transaction under AmerisourceBergen's broader federal contracting relationship. This...
- The Defense Logistics Agency awarded a $3,086.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg, with an ultimate completion date of September 2, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Onfil 10 mg tablets (100-count) with a ceiling value of $12,795.99. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 23, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $2,652.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg, with an ultimate completion date of October 20, 2025. This non-competitive delivery order was issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical supply vehicle valued through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Onfil 10 mg tablets (100-count units) with a ceiling value of $4,414.14. This competitive, non-set-aside award reflects a firm fixed-price delivery order placed against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million and extending through December 2026. The place of performance is...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEYB8Delivery Order
The Defense Logistics Agency (DLA) awarded a $18,170.57 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg on July 16, 2025, with an ultimate completion date of July 17, 2025. This firm fixed price contract represents a competitively awarded, non-set-aside procurement and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp serves as a primary pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through DLA's Medical Supply Chain. The company's federal contract portfolio demonstrates extensive experience delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a major pharmaceutical distributor headquartered in Pennsylvania and registered in the System for Award Management, AmerisourceBergen maintains significant capacity to fulfill federal medical supply requirements through open competition, as evidenced by the consistent award of competitively awarded delivery orders under its umbrella IDC.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.2k | 7/16/25 |